<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39339878</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>High Levels of Incidental COVID-19 Infection in Emergency Urology Admissions: A Propensity Score-Matched Real World Data Analysis across Surgical Specialties.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1402</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16091402</ELocationID><Abstract><AbstractText><b>Background:</b> An incidental COVID-19 infection is often found in patients admitted for non-COVID-19-related conditions. This study aims to investigate the incidence of COVID-19 infections across surgical specialties including urology, general surgery, and orthopaedic surgery. <b>Methods:</b> This is a retrospective cohort study based on a territory-wide electronic database in Hong Kong. All emergency in-hospital admissions under the urology, general surgery, and orthopaedic surgery divisions in the public healthcare system in Hong Kong from January to September 2022 were included. All patients were routinely screened for SARS-CoV-2, based on admission protocols during the investigation period. Baseline characteristics were retrieved, with 1:1:1 propensity score matching being performed. Incidental COVID-19 rates were then compared across specialties. <b>Results:</b> A total of 126,034 patients were included. After propensity score matching, the baseline characteristics were well balanced, and 8535 patients in each group were analysed. Urology admission was noted to have a statistically significant higher incidence of incidental COVID-19 at 9.3%, compared to general surgery (5.4%) or orthopaedic surgery (5.6%). Amongst urology patients with incidental COVID-19 infection, 35.8% were admitted for retention of urine, 27.9% for haematuria, and 8.6% for a urinary tract infection. <b>Conclusions:</b> This large-scale cohort study demonstrated that incidental COVID-19 rates differ between surgical specialties, with urology having the highest proportion of incidental COVID-19 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Alex Qinyang</ForeName><Initials>AQ</Initials><Identifier Source="ORCID">0000-0003-0302-0472</Identifier><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choy</LastName><ForeName>Eric Ka-Ho</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Peter Ka-Fung</ForeName><Initials>PK</Initials><Identifier Source="ORCID">0000-0002-1499-8372</Identifier><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yee</LastName><ForeName>Chi-Hang</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0001-6557-3107</Identifier><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Chi-Fai</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0002-1723-9646</Identifier><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teoh</LastName><ForeName>Jeremy Yuen-Chun</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0002-9361-2342</Identifier><AffiliationInfo><Affiliation>S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="Y">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013043" MajorTopicYN="N">Specialties, Surgical</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014572" MajorTopicYN="N">Urology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">acute urinary retention</Keyword><Keyword MajorTopicYN="N">surgery</Keyword><Keyword MajorTopicYN="N">urinary tract infection</Keyword><Keyword MajorTopicYN="N">urology</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39339878</ArticleId><ArticleId IdType="pmc">PMC11437490</ArticleId><ArticleId IdType="doi">10.3390/v16091402</ArticleId><ArticleId IdType="pii">v16091402</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sohrabi C., Alsafi Z., O’Neill N., Khan M., Kerwan A., Al-Jabir A., Iosifidis C., Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) Int. J. Surg. 2020;76:71–76. doi: 10.1016/j.ijsu.2020.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.034</ArticleId><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 28 May 2024)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017–1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J.G., Strasser Z.H., Hutch M.R., Kennedy C.J., Marwaha J.S., Morris M., Samayamuthu M.J., Pfaff A.C., Estiri H., South A.M., et al. Distinguishing Admissions Specifically for COVID-19 From Incidental SARS-CoV-2 Admissions: National Retrospective Electronic Health Record Study. J. Med. Internet Res. 2022;24:e37931. doi: 10.2196/37931.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37931</ArticleId><ArticleId IdType="pmc">PMC9119395</ArticleId><ArticleId IdType="pubmed">35476727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S., Lim W.Y., Ong J., Kam P. Anesthesia guidelines for COVID-19 patients: A narrative review and appraisal. Korean J. Anesthesiol. 2020;73:486–502. doi: 10.4097/kja.20354.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.20354</ArticleId><ArticleId IdType="pmc">PMC7714635</ArticleId><ArticleId IdType="pubmed">32668835</ArticleId></ArticleIdList></Reference><Reference><Citation>You Y., Yang X., Hung D., Yang Q., Wu T., Deng M. Asymptomatic COVID-19 infection: Diagnosis, transmission, population characteristics. BMJ Support. Palliat. Care. 2021;14:e220–e227. doi: 10.1136/bmjspcare-2020-002813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjspcare-2020-002813</ArticleId><ArticleId IdType="pubmed">34330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H., Seddighzadeh B., Cooperberg M.R., Huang F.W. Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells. Eur. Urol. 2020;78:296–298. doi: 10.1016/j.eururo.2020.04.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2020.04.065</ArticleId><ArticleId IdType="pmc">PMC7200365</ArticleId><ArticleId IdType="pubmed">32418620</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu A.Q., Chiu P.K., Yee S.C., Ng C.F., Teoh J.Y. SARS-CoV-2 infection correlates with male benign prostatic hyperplasia deterioration. J. Intern. Med. 2023;294:775–783. doi: 10.1111/joim.13719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13719</ArticleId><ArticleId IdType="pubmed">37849423</ArticleId></ArticleIdList></Reference><Reference><Citation>Hostpital Authority  HA Statistical Report.  [(accessed on 25 June 2024)].  Available online:  https://www3.ha.org.hk/data/HAStatistics/StatisticalReport/</Citation></Reference><Reference><Citation>Wong J.C., Chan H.L., Tse Y.K., Yip T.C., Wong V.W., Wong G.L. Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: A propensity score weighted landmark analysis. Aliment. Pharmacol. Ther. 2017;46:1001–1010. doi: 10.1111/apt.14341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14341</ArticleId><ArticleId IdType="pubmed">28940673</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister F.A., Hau J.P., Atzema C., McRae A.D., Morrison L.J., Grant L., Cheng I., Rosychuk R.J., Hohl C.M. The burden of incidental SARS-CoV-2 infections in hospitalized patients across pandemic waves in Canada. Sci. Rep. 2023;13:6635. doi: 10.1038/s41598-023-33569-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33569-2</ArticleId><ArticleId IdType="pmc">PMC10123574</ArticleId><ArticleId IdType="pubmed">37095174</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolla D.A., Oskvarek J.J., Zocchi M.S., Rahman N.A., Leubitz A., Moghtaderi A., Black B.S., Pines J.M. Defining Incidental Versus Non-incidental COVID-19 Hospitalizations. Cureus. 2024;16:e56546. doi: 10.7759/cureus.56546.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.56546</ArticleId><ArticleId IdType="pmc">PMC11027788</ArticleId><ArticleId IdType="pubmed">38646211</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Polidori L., Antonelli M., Penamakuri S., Nogal A., Figueiredo J.C., Hu C., Molteni E. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study. Lancet. 2022;399:1618–1624. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaphas A., Gkoufa K., Colucci N., Perdikis K.C., Gaudet-Blavignac C., Pataky Z., Carballo S., Ris F., Stirnemann J., Lovis C., et al. Abdominal pain patterns during COVID-19: An observational study. Sci. Rep. 2022;12:14677. doi: 10.1038/s41598-022-18753-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18753-0</ArticleId><ArticleId IdType="pmc">PMC9421623</ArticleId><ArticleId IdType="pubmed">36038578</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheman F.J., Rojoa D.M., Nayan Parekh J., Berber R., Ashford R. Meta-analysis and metaregression of risk factors associated with mortality in hip fracture patients during the COVID-19 pandemic. Sci. Rep. 2021;11:10157. doi: 10.1038/s41598-021-89617-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89617-2</ArticleId><ArticleId IdType="pmc">PMC8115062</ArticleId><ArticleId IdType="pubmed">33980936</ArticleId></ArticleIdList></Reference><Reference><Citation>Isla A., Landy D., Teasdall R., Mittwede P., Albano A., Tornetta P., 3rd, Bhandari M., Aneja A. Postoperative mortality in the COVID-positive hip fracture patient, a systematic review and meta-analysis. Eur. J. Orthop. Surg. Traumatol. 2023;33:927–935. doi: 10.1007/s00590-022-03228-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00590-022-03228-9</ArticleId><ArticleId IdType="pmc">PMC8864596</ArticleId><ArticleId IdType="pubmed">35195751</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui K.H.M., Chau W.W., Liu W.H., Tam C.Y., Yee D.K.H., Tso C.Y., Zhang N., Cheung W.H., Tang N., Wong R.M. COVID-19 hip fracture outcomes: The role of Ct values and D-dimer levels? J. Orthop. Translat. 2023;43:14–20. doi: 10.1016/j.jot.2023.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2023.09.008</ArticleId><ArticleId IdType="pmc">PMC10618614</ArticleId><ArticleId IdType="pubmed">37920546</ArticleId></ArticleIdList></Reference><Reference><Citation>Todor S.B., Bîrluțiu V., Topîrcean D., Mihăilă R.G. Role of biological markers and CT severity score in predicting mortality in patients with COVID-19: An observational retrospective study. Exp. Ther. Med. 2022;24:698. doi: 10.3892/etm.2022.11634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11634</ArticleId><ArticleId IdType="pmc">PMC9535394</ArticleId><ArticleId IdType="pubmed">36277141</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>